{
    "id": 86,
    "premise": "none",
    "hypothesis": "Unknown whether patient will be appropriate for immune checkpoint inhibitors",
    "label": "entailment",
    "explanation": "Patient PD-L1 status unknown.\nImmune checkpoint inhibitors have had promising outcomes in TNBC.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "Unknown whether patient will be appropriate for immune checkpoint inhibitors",
        "refined explanation": "Patient PD-L1 status unknown.\nImmune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status, indicating that known PD-L1 status is crucial for determining treatment success.\nThe appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient's PD-L1 status.\nIf a patient's PD-L1 status is unknown, it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors, as the determination of appropriateness relies on known PD-L1 status.",
        "refined iteration": 4,
        "history explanation": [
            "0 iteration: Patient PD-L1 status unknown.\nImmune checkpoint inhibitors have had promising outcomes in TNBC.",
            "1 iteration: Patient PD-L1 status unknown.\nImmune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status.\nThe appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient's PD-L1 status.",
            "2 iteration: Patient PD-L1 status unknown.\nImmune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status.\nThe appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient's PD-L1 status.\nIf a patient's PD-L1 status is unknown, it is unknown whether the patient will be appropriate for immune checkpoint inhibitors.",
            "3 iteration: Patient PD-L1 status unknown.\nImmune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status, indicating that known PD-L1 status is crucial for determining treatment success.\nThe appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient's PD-L1 status.\nIf a patient's PD-L1 status is unknown, it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors, as the determination of appropriateness relies on known PD-L1 status.",
            "4 iteration: Patient PD-L1 status unknown.\nImmune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status, indicating that known PD-L1 status is crucial for determining treatment success.\nThe appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient's PD-L1 status.\nIf a patient's PD-L1 status is unknown, it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors, as the determination of appropriateness relies on known PD-L1 status."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': \"(* Explanation 1 states that if a patient's PD-L1 status is known, it is unknown. *)\\n(* However, this does not directly relate to the appropriateness for immune checkpoint inhibitors. *)\\n(* Explanation 2 provides information about the outcomes of immune checkpoint inhibitors in TNBC, but does not directly relate to the appropriateness for a specific patient. *)\\n(* Since there is no direct logical relation or derived implication connecting the premise to the hypothesis, we cannot infer the hypothesis directly from the given explanations. *)\\n(* Therefore, the hypothesis remains unknown based on the provided information. *)\\nthen show ?thesis sledgehammer\", 'solving time': 103.88161063194275, 'proof tactics': [], 'code': 'theory clinical_86_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PatientPDL1Status :: \"entity \u21d2 bool\"\\n  Unknown :: \"entity \u21d2 bool\"\\n  ImmuneCheckpointInhibitors :: \"entity \u21d2 bool\"\\n  Outcomes :: \"entity \u21d2 bool\"\\n  Promising :: \"entity \u21d2 bool\"\\n  TNBC :: \"entity \u21d2 bool\"\\n  Had :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  AppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient PD-L1 status unknown. *)\\naxiomatization where\\n  explanation_1: \"\u2200x. PatientPDL1Status x \u27f6 Unknown x\"\\n\\n(* Explanation 2: Immune checkpoint inhibitors have had promising outcomes in TNBC. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. ImmuneCheckpointInhibitors x \u2227 Outcomes y \u2227 Promising y \u2227 TNBC z \u2227 Had e \u2227 Agent e x \u2227 Patient e y \u2227 In y z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patient e x \u2227 ImmuneCheckpointInhibitors y\"\\n  (* Hypothesis: Unknown whether patient will be appropriate for immune checkpoint inhibitors. *)\\n  shows \"\u2200x y. (\u2203e. Patient e x \u2227 ImmuneCheckpointInhibitors y) \u27f6 AppropriateFor x y\"\\nproof -\\n  (* From the premise, we have known information about the patient and immune checkpoint inhibitors. *)\\n  from asm have \"Patient e x \u2227 ImmuneCheckpointInhibitors y\" <ATP>\\n  (* Explanation 1 states that if a patient\\'s PD-L1 status is known, it is unknown. *)\\n  (* However, this does not directly relate to the appropriateness for immune checkpoint inhibitors. *)\\n  (* Explanation 2 provides information about the outcomes of immune checkpoint inhibitors in TNBC, but does not directly relate to the appropriateness for a specific patient. *)\\n  (* Since there is no direct logical relation or derived implication connecting the premise to the hypothesis, we cannot infer the hypothesis directly from the given explanations. *)\\n  (* Therefore, the hypothesis remains unknown based on the provided information. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient PD-L1 status is unknown (from Explanatory Sentence 1)\\nB: Immune checkpoint inhibitors have had promising outcomes in TNBC (from Explanatory Sentence 2)\\n\\nLogical Relations:\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': 'then show ?thesis sledgehammer', 'solving time': 119.78654074668884, 'proof tactics': [], 'code': 'theory clinical_86_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PatientPDL1Status :: \"entity \u21d2 bool\"\\n  Unknown :: \"entity \u21d2 bool\"\\n  ImmuneCheckpointInhibitors :: \"entity \u21d2 bool\"\\n  Outcomes :: \"entity \u21d2 bool\"\\n  TNBC :: \"entity \u21d2 bool\"\\n  Promising :: \"entity \u21d2 bool\"\\n  Had :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  KnownPDL1Status :: \"entity \u21d2 bool\"\\n  PDL1Status :: \"entity \u21d2 bool\"\\n  Appropriateness :: \"entity \u21d2 entity \u21d2 bool\"\\n  Determined :: \"event \u21d2 bool\"\\n  Often :: \"event \u21d2 bool\"\\n  AppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient PD-L1 status unknown *)\\naxiomatization where\\n  explanation_1: \"\u2200x. PatientPDL1Status x \u27f6 Unknown x\"\\n\\n(* Explanation 2: Immune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. ImmuneCheckpointInhibitors x \u2227 Outcomes y \u2227 TNBC z \u2227 Promising y \u2227 Had e \u2227 Agent e x \u2227 Patient y \u2227 In y z \u2227 KnownPDL1Status y\"\\n\\n(* Explanation 3: The appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient\\'s PD-L1 status *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e. ImmuneCheckpointInhibitors x \u2227 Patient y \u2227 PDL1Status z \u2227 Appropriateness x y \u2227 Determined e \u2227 Agent e z \u2227 Often e\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patient x \u2227 ImmuneCheckpointInhibitors y\"\\n  (* Hypothesis: Unknown whether patient will be appropriate for immune checkpoint inhibitors *)\\n  shows \"\u2200x y. Patient x \u2227 ImmuneCheckpointInhibitors y \u27f6 AppropriateFor x y\"\\nproof -\\n  (* From the premise, we have known information about the patient and immune checkpoint inhibitors. *)\\n  from asm have \"Patient x \u2227 ImmuneCheckpointInhibitors y\" <ATP>\\n  (* Explanation 1 states that if the Patient PD-L1 status is unknown, it implies Unknown. *)\\n  (* Explanation 3 states that the appropriateness of immune checkpoint inhibitors is determined by the patient\\'s PD-L1 status. *)\\n  (* Since the PD-L1 status is unknown, we cannot determine the appropriateness. *)\\n  (* Therefore, it is unknown whether the patient will be appropriate for immune checkpoint inhibitors. *)\\n  then have \"Unknown (AppropriateFor x y)\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient PD-L1 status is known (from Explanatory Sentence 1 and 2)\\nB: Immune checkpoint inhibitors have promising outcomes (from Explanatory Sentence 2)\\nC: Appropriateness of immune checkpoint inhibitors for a patient (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(Patient PD-L1 status is known, Immune checkpoint inhibitors have promising outcomes)\\n--------\\nImplies(A, C)\\nImplies(Patient PD-L1 status is known, Appropriateness of immune checkpoint inhibitors for a patient)\\n--------\\n\\nDerived Implications:\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '(* We need to show that there exists a patient x such that it is unknown whether they are appropriate for immune checkpoint inhibitors. *)\\nthen show ?thesis sledgehammer', 'solving time': 118.75736498832703, 'proof tactics': [], 'code': 'theory clinical_86_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PatientPDL1Status :: \"entity \u21d2 bool\"\\n  Unknown :: \"entity \u21d2 bool\"\\n  ImmuneCheckpointInhibitors :: \"entity \u21d2 bool\"\\n  PromisingOutcomes :: \"entity \u21d2 bool\"\\n  TNBC :: \"entity \u21d2 bool\"\\n  Had :: \"entity \u21d2 bool\"\\n  PatientPDL1StatusKnown :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  ParticularlyIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  AppropriatenessFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  DeterminedBy :: \"entity \u21d2 entity \u21d2 entity \u21d2 bool\"\\n  Often :: \"entity \u21d2 bool\"\\n  AppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient PD-L1 status unknown *)\\naxiomatization where\\n  explanation_1: \"\u2203x. PatientPDL1Status x \u2227 Unknown x\"\\n\\n(* Explanation 2: Immune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w. ImmuneCheckpointInhibitors x \u2227 PromisingOutcomes y \u2227 TNBC z \u2227 Had y \u2227 PatientPDL1StatusKnown w \u2227 In y z \u2227 ParticularlyIn y w\"\\n\\n(* Explanation 3: The appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient\\'s PD-L1 status *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z. ImmuneCheckpointInhibitors x \u2227 Patient y \u2227 AppropriatenessFor x y \u2227 PatientPDL1Status z \u2227 DeterminedBy z x y \u2227 Often z\"\\n\\n(* Explanation 4: If a patient\\'s PD-L1 status is unknown, it is unknown whether the patient will be appropriate for immune checkpoint inhibitors *)\\naxiomatization where\\n  explanation_4: \"\u2200x y z. (PatientPDL1Status x \u2227 Unknown x) \u27f6 (Patient y \u2227 Unknown y \u2227 ImmuneCheckpointInhibitors z)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patient x\"\\n  (* Hypothesis: Unknown whether patient will be appropriate for immune checkpoint inhibitors *)\\n  shows \"\u2203x. Patient x \u2227 AppropriateFor x y \u2227 ImmuneCheckpointInhibitors y\"\\nproof -\\n  (* From Explanation 1, we know there exists a patient with unknown PD-L1 status. *)\\n  from explanation_1 obtain a where \"PatientPDL1Status a \u2227 Unknown a\" <ATP>\\n  (* Explanation 4 states that if a patient\\'s PD-L1 status is unknown, it is unknown whether the patient will be appropriate for immune checkpoint inhibitors. *)\\n  then have \"Patient x \u2227 Unknown x \u2227 ImmuneCheckpointInhibitors y\" <ATP>\\n  (* We need to show that there exists a patient x such that it is unknown whether they are appropriate for immune checkpoint inhibitors. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient PD-L1 status is known (from Explanatory Sentence 1 and 4)\\nB: Immune checkpoint inhibitors have promising outcomes in TNBC (from Explanatory Sentence 2)\\nC: Patient is appropriate for immune checkpoint inhibitors (from Explanatory Sentence 3 and 4)\\n\\nLogical Relations:\\nImplies(Not(A), Not(C))\\nImplies(Not(Patient PD-L1 status is known), Not(Patient is appropriate for immune checkpoint inhibitors))\\n--------\\nImplies(A, C)\\nImplies(Patient PD-L1 status is known, Patient is appropriate for immune checkpoint inhibitors)\\n--------\\nImplies(A, B)\\nImplies(Patient PD-L1 status is known, Immune checkpoint inhibitors have promising outcomes in TNBC)\\n--------\\n\\nDerived Implications:\\nImplies(C, B)\\nImplies(Patient is appropriate for immune checkpoint inhibitors, Immune checkpoint inhibitors have promising outcomes in TNBC)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(Immune checkpoint inhibitors have promising outcomes in TNBC), Not(Patient is appropriate for immune checkpoint inhibitors))\\n--------\\n'}",
            "3 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 8.235045433044434, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  UnknownAppropriateFor x :: entity \\\\<Rightarrow> bool\\nOperand:   ImmuneCheckpointInhibitors :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_86_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PatientPDL1Status :: \"entity \u21d2 bool\"\\n  Unknown :: \"entity \u21d2 bool\"\\n  ImmuneCheckpointInhibitors :: \"entity \u21d2 bool\"\\n  Outcomes :: \"entity \u21d2 bool\"\\n  TNBC :: \"entity \u21d2 bool\"\\n  Promising :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  KnownPDL1Status :: \"entity \u21d2 bool\"\\n  Have :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  CrucialForTreatmentSuccess :: \"entity \u21d2 bool\"\\n  OftenDeterminedBy :: \"entity \u21d2 entity \u21d2 bool\"\\n  Appropriateness :: \"entity \u21d2 entity \u21d2 entity\"  (* Changed to return entity *)\\n  PDL1Status :: \"entity \u21d2 bool\"\\n  UncertainAppropriateFor :: \"entity \u21d2 bool\"  (* Changed to take a single entity *)\\n  ReliesOn :: \"entity \u21d2 entity \u21d2 bool\"\\n  DeterminationOfAppropriateness :: \"entity \u21d2 entity \u21d2 bool\"\\n  UnknownAppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient PD-L1 status unknown *)\\naxiomatization where\\n  explanation_1: \"\u2200x. PatientPDL1Status x \u27f6 Unknown x\"\\n\\n(* Explanation 2: Immune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status, indicating that known PD-L1 status is crucial for determining treatment success *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. ImmuneCheckpointInhibitors x \u2227 Outcomes y \u2227 TNBC z \u2227 Promising e1 \u2227 Patient e1 y \u2227 In y z \u2227 KnownPDL1Status y \u2227 Have e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Indicate e2 \u2227 (KnownPDL1Status y \u27f6 CrucialForTreatmentSuccess y)\"\\n\\n(* Explanation 3: The appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient\\'s PD-L1 status *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e. ImmuneCheckpointInhibitors x \u2227 Patient e y \u2227 PDL1Status z \u27f6 OftenDeterminedBy (Appropriateness x y) z\"\\n\\n(* Explanation 4: If a patient\\'s PD-L1 status is unknown, it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors, as the determination of appropriateness relies on known PD-L1 status *)\\naxiomatization where\\n  explanation_4: \"\u2200x y z e. (Patient e x \u2227 PDL1Status y \u2227 Unknown y) \u27f6 (UncertainAppropriateFor x \u2227 ReliesOn z y \u2227 KnownPDL1Status y)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patient e x\"\\n  (* Hypothesis: Unknown whether patient will be appropriate for immune checkpoint inhibitors *)\\n  shows \"\u2200x. (\u2203e. Patient e x) \u27f6 UnknownAppropriateFor x ImmuneCheckpointInhibitors\"\\nproof -\\n  (* From the premise, we have a patient e x. *)\\n  from asm have \"Patient e x\" <ATP>\\n  (* Explanation 4 states that if a patient\\'s PD-L1 status is unknown, it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors. *)\\n  (* We need to show that for any patient, if there exists an event e such that Patient e x, then it is unknown whether the patient will be appropriate for immune checkpoint inhibitors. *)\\n  (* Explanation 1 states that Patient PD-L1 status unknown implies Unknown. *)\\n  (* Using Explanation 4, we can infer that if the PD-L1 status is unknown, then it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors. *)\\n  then have \"UnknownAppropriateFor x ImmuneCheckpointInhibitors\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient PD-L1 status is known (from Explanatory Sentence 1 and 2)\\nB: Immune checkpoint inhibitors have promising outcomes (from Explanatory Sentence 2)\\nC: Appropriateness of immune checkpoint inhibitors for a patient (from Explanatory Sentence 3)\\nD: It is certain whether the patient will be appropriate for immune checkpoint inhibitors (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(Not(A), Not(D))\\nImplies(Not(Patient PD-L1 status is known), Not(It is certain whether the patient will be appropriate for immune checkpoint inhibitors))\\n--------\\nImplies(A, C)\\nImplies(Patient PD-L1 status is known, Appropriateness of immune checkpoint inhibitors for a patient)\\n--------\\nImplies(C, B)\\nImplies(Appropriateness of immune checkpoint inhibitors for a patient, Immune checkpoint inhibitors have promising outcomes)\\n--------\\n\\nDerived Implications:\\nImplies(Not(B), Not(D))\\nImplies(Not(Immune checkpoint inhibitors have promising outcomes), Not(It is certain whether the patient will be appropriate for immune checkpoint inhibitors))\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(Appropriateness of immune checkpoint inhibitors for a patient), Not(It is certain whether the patient will be appropriate for immune checkpoint inhibitors))\\n--------\\nImplies(D, B)\\nImplies(It is certain whether the patient will be appropriate for immune checkpoint inhibitors, Immune checkpoint inhibitors have promising outcomes)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(Immune checkpoint inhibitors have promising outcomes), Not(Patient PD-L1 status is known))\\n--------\\nImplies(D, C)\\nImplies(It is certain whether the patient will be appropriate for immune checkpoint inhibitors, Appropriateness of immune checkpoint inhibitors for a patient)\\n--------\\nImplies(A, B)\\nImplies(Patient PD-L1 status is known, Immune checkpoint inhibitors have promising outcomes)\\n--------\\n'}",
            "4 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 9.01848316192627, 'proof tactics': ['Sledgehammering...', 'cvc4 found a proof...', 'zipperposition found a proof...', 'cvc4: Try this: using explanation_3 by blast (5 ms)', 'zipperposition: Found duplicate proof', 'spass found a proof...', 'cvc4 found a proof...', 'cvc4 found a proof...', 'cvc4: Found duplicate proof', 'zipperposition found a proof...', 'cvc4: Found duplicate proof', 'verit found a proof...', 'spass: Found duplicate proof', 'vampire found a proof...', 'verit: Try this: using explanation_3 by presburger (5 ms)', 'zipperposition: Found duplicate proof', 'zipperposition found a proof...', 'e found a proof...', 'zipperposition: Found duplicate proof', 'vampire: Found duplicate proof', 'e: Found duplicate proof', 'Done'], 'code': 'theory clinical_86_4\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PatientStatus :: \"entity \u21d2 bool\"\\n  Unknown :: \"entity \u21d2 bool\"\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Outcomes :: \"entity \u21d2 bool\"\\n  TNBC :: \"entity \u21d2 bool\"\\n  Had :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Known :: \"entity \u21d2 bool\"\\n  CrucialFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  Success :: \"entity \u21d2 bool\"\\n  Status :: \"entity \u21d2 bool\"\\n  Determined :: \"event \u21d2 bool\"\\n  AppropriateFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  Uncertain :: \"event \u21d2 bool\"\\n  Determination :: \"event \u21d2 bool\"\\n  ReliesOn :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Patient PD-L1 status unknown *)\\naxiomatization where\\n  explanation_1: \"\u2200x. PatientStatus x \u27f6 Unknown x\"\\n\\n(* Explanation 2: Immune checkpoint inhibitors have had promising outcomes in TNBC, particularly in patients with known PD-L1 status, indicating that known PD-L1 status is crucial for determining treatment success *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. Inhibitors x \u2227 Outcomes y \u2227 TNBC z \u2227 Had e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 In y z \u2227 PatientStatus e2 \u2227 Known e2 \u2227 CrucialFor e2 y \u2227 Success y\"\\n\\n(* Explanation 3: The appropriateness of immune checkpoint inhibitors for a patient is often determined by the patient\\'s PD-L1 status *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e. Inhibitors x \u2227 Patient e y \u2227 Status z \u2227 Determined e \u2227 Agent e z \u2227 Patient e x \u2227 AppropriateFor x y\"\\n\\n(* Explanation 4: If a patient\\'s PD-L1 status is unknown, it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors, as the determination of appropriateness relies on known PD-L1 status *)\\naxiomatization where\\n  explanation_4: \"\u2200x y z e1 e2. Patient e1 x \u2227 Status y \u2227 Inhibitors z \u2227 Unknown y \u27f6 ((Uncertain e1 \u2227 AppropriateFor x z) \u2227 (Determination e2 \u2227 ReliesOn e2 y \u2227 Known y))\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Patient e x \u2227 Inhibitors y\"\\n  (* Hypothesis: Unknown whether patient will be appropriate for immune checkpoint inhibitors *)\\n  shows \"\u2200x y. Patient e x \u2227 Inhibitors y \u27f6 AppropriateFor x y\"\\nproof -\\n  (* From the premise, we have known information about the patient and inhibitors. *)\\n  from asm have \"Patient e x \u2227 Inhibitors y\" <ATP>\\n  (* Explanation 4 states that if a patient\\'s PD-L1 status is unknown, it is uncertain whether the patient will be appropriate for immune checkpoint inhibitors. *)\\n  (* We have the logical relation Implies(Not(A), Not(C)), which means if the patient\\'s PD-L1 status is not known, the patient is not appropriate for immune checkpoint inhibitors. *)\\n  (* Since the status is unknown, we can infer uncertainty about appropriateness. *)\\n  then have \"Uncertain e \u2227 AppropriateFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Patient PD-L1 status is known (from Explanatory Sentence 1 and 2)\\nB: Immune checkpoint inhibitors have promising outcomes (from Explanatory Sentence 2)\\nC: Patient is appropriate for immune checkpoint inhibitors (from Explanatory Sentence 3 and 4)\\n\\nLogical Relations:\\nImplies(Not(A), Not(C))\\nImplies(Not(Patient PD-L1 status is known), Not(Patient is appropriate for immune checkpoint inhibitors))\\n--------\\nImplies(A, C)\\nImplies(Patient PD-L1 status is known, Patient is appropriate for immune checkpoint inhibitors)\\n--------\\nImplies(A, B)\\nImplies(Patient PD-L1 status is known, Immune checkpoint inhibitors have promising outcomes)\\n--------\\n\\nDerived Implications:\\nImplies(C, B)\\nImplies(Patient is appropriate for immune checkpoint inhibitors, Immune checkpoint inhibitors have promising outcomes)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(Immune checkpoint inhibitors have promising outcomes), Not(Patient is appropriate for immune checkpoint inhibitors))\\n--------\\n'}"
        ]
    }
}